Skip to main content
NIH funding notice PAR-20-225

Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)

Closed on October 19, 2022.

Posted
June 1, 2020
Close date
October 19, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

11 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,433,750 in first-year total cost, median $491,250.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 IXN-O (02)]4
  2. Special Emphasis Panel[ZDA1 IXR-Q (04)]4
  3. Special Emphasis Panel[ZDA1 IXR-Q (M1)]3

Most frequent institutions

  1. BRIGHAM AND WOMEN'S HOSPITAL1
  2. JOHNS HOPKINS UNIVERSITY1
  3. OHIO STATE UNIVERSITY1
  4. OREGON HEALTH & SCIENCE UNIVERSITY1
  5. PENNSYLVANIA STATE UNIV HERSHEY MED CTR1
Competing awards under PAR-20-225 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Deciphering the single-nucleus genomic regulatory structure of opioid use disorder in the human brain1DP1DA058737-01MONTALVO-ORTIZ, JANITZA LIZYALE UNIVERSITY, CT$502,500ZDA1
2023Identifying multi-omic signatures of opioid use and relapse1DP1DA058661-01FOX, MEGAN ELIZABETHPENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA$498,000ZDA1
2023High-Throughput Functional Genomics of Variants in Genes Linked to Substance Use Disorders1DP1DA058706-01BALDRIDGE, DUSTIN MWASHINGTON UNIVERSITY, MO$466,500ZDA1
2022Impact of maternal marijuana use on epigenetic regulation of offspring neurodevelopment1DP1DA056493-01LO, JAMIEOREGON HEALTH & SCIENCE UNIVERSITY, OR$525,000ZDA1
2022IDENTIFYING EPIGENOMICS AND CONNECTOMICS OF PROTRACTED OPIOID WITHDRAWAL AND RELAPSE USING CELLULAR BARCODING1DP1DA056668-01KEBSCHULL, JUSTUS MJOHNS HOPKINS UNIVERSITY, MD$491,250ZDA1
2022Framework to Accelerate Substance Use Disorder Genetic Studies through Customizable, EHR-Based Precision Phenotyping1DP1DA056667-01JEFFERY, ALVIN DEANVANDERBILT UNIVERSITY, TN$475,500ZDA1
2022The role of DNA breaks and repairs in opioid addiction1DP1DA056804-01WANG, ZIJUNUNIVERSITY OF KANSAS LAWRENCE, KS$459,000ZDA1
2021Epigenomic labeling of cells that drive drug abuse behavior1DP1DA054343-01RENTHAL, WILLIAM RUSSELLBRIGHAM AND WOMEN'S HOSPITAL, MA$537,000ZDA1
2021Identifying specific genetic pathway interactions for drug use and abuse through integrative omics1DP1DA054373-01PENG, QIANSCRIPPS RESEARCH INSTITUTE, THE, CA$532,500ZDA1
2021Building Bridges to Allow Cross-species Translational genetics for the Study of Addiction1DP1DA054394-01SANCHEZ ROIGE, SANDRAUNIVERSITY OF CALIFORNIA, SAN DIEGO, CA$474,000ZDA1
2021X chromosome inactivation in sex disparities to substance use disorder1DP1DA054344-01OGHUMU, STEVE ONYEKAOHIO STATE UNIVERSITY, OH$472,500ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.